Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

American Society of Clinical Oncology

Tracked across 36 events · 624 articles · First seen May 06, 2025 · Last active Sep 11, 2026

Sentiment
16
Attention
8
Events
36
Relationships
12
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
7 70
Tech
Impact: The American Society of Clinical Oncology (ASCO) is the host of the annual meeting where new cancer research and clinical development advances are presented, making it a central entity for this event.
May 25, 2026 · 33 articles
8 40
Tech
Impact: The American Society of Clinical Oncology>>> Annual Meeting served as the platform for presenting the significant research findings on GLP-1 receptor agonist and breast cancer prevention.
Jun 02, 2026 · 45 articles
6 50
Tech
Impact: The American Society of Clinical Oncology is hosting its annual meeting where the groundbreaking results of the OPTIMA trial are being presented, disseminating the findings to a global audience of cancer specialists.
May 29, 2026 · 21 articles
3 20
Tech
Impact: ASCO highlighted the study in its press center and Science in Seconds, lending credibility to the technology.
Jul 06, 2026 · 6 articles
4 20
Tech
Impact: The American Society of Clinical Oncology hosted the annual meeting where the study results for SKB500 were presented, serving as a key platform for disseminating medical advancements.
Jun 03, 2026 · 6 articles
2 10
Domestic
Impact: ASCO co-organized the conference and partners with AORTIC for workforce development.
Jul 11, 2026 · 9 articles
4 0
Tech
Impact: The annual meeting served as a platform for presenting new research on GLP-1 drugs and cancer, contributing to the scientific discourse and media attention.
Jul 13, 2026 · 6 articles
4 20
Tech
Impact: The American Society of Clinical Oncology (ASCO) hosted the annual meeting where Dassault Systèmes — Medidata Solutions unveiled its new solution, serving as a platform for the announcement and contributing to the dissemination of the technology.
May 28, 2026 · 6 articles
4 0
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Moleculin Biotech to present its positive cardiac safety data for Annamycin.
May 21, 2026 · 7 articles
4 0
Tech
Impact: The American Society of Clinical Oncology (ASCO) is hosting its Annual Meeting where Molecular Partners will present trial-in-progress poster presentations on MP0712.
May 30, 2026 · 8 articles
4 0
Tech
Impact: The American Society of Clinical Oncology Annual Meeting served as the platform for Orion to present its initial clinical data for ODM-212.
May 21, 2026 · 6 articles
6 50
Tech
Impact: The American Society of Clinical Oncology>>> is hosting the presentation of the trial results, solidifying its role as a central platform for disseminating significant cancer research. This event enhances its prestige and influence within the oncology community.
Jun 01, 2026 · 6 articles
7 50
Tech
Impact: The results of the amivantamab trial are being presented at the annual meeting of the American Society of Clinical Oncology, providing a platform for wider recognition of the breakthrough.
May 30, 2026 · 20 articles
6 0
Tech
Impact: The American Society of Clinical Oncology is hosting the annual meeting where Fulgent Genetics presented its FID-007 data, providing a platform for the dissemination of important clinical research.
May 21, 2026 · 8 articles
6 60
Tech
Impact: The meeting of the American Society of Clinical Oncology>>> highlighted significant studies and trial results for new life-extending cancer drugs.
Jun 03, 2026 · 6 articles
6 0
Tech
Impact: The organization hosted the annual meeting where the Phase III clinical study results were presented as an oral presentation, providing a platform for dissemination of the findings.
May 30, 2026 · 14 articles
4 0
Regulatory
Impact: ASCO is the venue where the clinical data supporting the BTD was presented. Its annual meeting serves as a platform for disseminating key efficacy and safety results, contributing to the credibility of the therapy.
Aug 03, 2026 · 6 articles
7 50
Tech
Impact: The American Society of Clinical Oncology meeting in Chicago was the venue where the significant findings of the daraxonrasib study were presented to the medical community.
May 29, 2026 · 74 articles
6 0
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting is the platform where the updated clinical data for IBI363 was presented, providing a significant forum for disseminating these important findings to the medical and scientific community.
May 21, 2026 · 9 articles
4 0
Tech
Impact: The American Society of Clinical Oncology (ASCO) Annual Meeting served as the platform for Dizal Pharmaceutical to present its clinical trial results, providing a credible forum for dissemination.
May 31, 2026 · 6 articles
6 0
Tech
Impact: The American Society of Clinical Oncology>>> meeting served as the platform for presenting the groundbreaking trial data for Apalutamide>>>.
May 31, 2026 · 6 articles
2 20
Tech
Impact: ASCO collaborated on the guideline, reinforcing its role in multidisciplinary cancer care and potentially influencing its members' practices.
Aug 13, 2026 · 6 articles
2 0
Tech
A new study led by researchers at the University of Miami Miller School of Medicine and its Sylvester Comprehensive Cancer Center found that alcohol-attributable cancer deaths in the United States more than doubled between 1990…
Impact: Hosted the presentation of the study's findings at its 2025 annual meeting.
Sep 03, 2026 · 23 articles
3 0
Regulatory
Impact: The RINGSIDE trial results were presented at the 2026 ASCO Annual Meeting, providing a platform for data dissemination.
Jul 08, 2026 · 6 articles
7 50
Regulatory
Impact: ASCO hosted the presentation of the pivotal trial results, which received a standing ovation, highlighting the significance of the data.
Aug 26, 2026 · 92 articles
7 60
Tech
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy Pembrolizumab, met its primary and secondary endpoints in a Phase 3 trial involving 1,137 patients…
Impact: ASCO's chief medical officer called the trial a 'monumental leap forward,' validating mRNA technology. The society may see increased engagement and research in this area.
Aug 19, 2026 · 126 articles
4 0
Business
Impact: ASCO hosted presentation of WU-KONG28 trial results as a Late-Breaking Abstract.
Jul 14, 2026 · 8 articles
3 10
Business
Impact: ASCO meetings provided the platform where positive data for the programs were presented, validating their potential.
Jul 21, 2026 · 7 articles
1 0
Business
Impact: ASCO is mentioned as the venue where results from the VIKTORIA-1 trial were presented. The event does not involve new ASCO actions, but the presentation is part of the company's clinical development history.
Aug 06, 2026 · 6 articles
4 0
Business
May 14, 2026 · 6 articles
+ 6 more events View on Dashboard
China — National Medical Products Administration ↔ American Society of Clinical Oncology
China — National Medical Products Administration ↔ American Society of Clinical Oncology
Merck & Co. ↔ American Society of Clinical Oncology
Merck & Co. ↔ American Society of Clinical Oncology
United States — Food and Drug Administration ↔ American Society of Clinical Oncology
United States — Food and Drug Administration ↔ American Society of Clinical Oncology
United States ↔ American Society of Clinical Oncology
United States ↔ American Society of Clinical Oncology
Australia ↔ American Society of Clinical Oncology
Australia ↔ American Society of Clinical Oncology
United Kingdom ↔ American Society of Clinical Oncology
United Kingdom ↔ American Society of Clinical Oncology
ERGEN INTELLIGENCE
Track American Society of Clinical Oncology live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.